ロード中...
Pneumocystis jirovecii pneumonia following everolimus treatment of metastatic breast cancer
Everolimus is an inhibitor of mammalian target of rapamycin with anti-tumour activity. While everolimus is known to cause drug-induced pneumonitis, it is rarely associated with Pneumocystis jirovecii pneumonia (PJP). We report a patient on everolimus therapy for metastatic breast cancer that develop...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4216328/ https://ncbi.nlm.nih.gov/pubmed/25379397 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mmcr.2014.08.007 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|